Market Maker Surveillance Report. TLT, GDXJ, CBIS, MJNA, JNUG, ABEV, Highest Net Sell Volume and Negative Price Friction For T
February 9, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 5251 companies with "abnormal" market making, 4227 companies with positive Friction Factors and 2167 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Thursday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. iSh 20+Y Trs Bd Shs (NASDAQ:TLT), MARKET VECTORS ETF TRJR GOLD MINES (NYSE:GDXJ), CANNABIS SCIENCE Inc. (OTC:CBIS), MEDICAL MARIJUANA I (OTC:MJNA), Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG), Ambev S.A. (NYSE:ABEV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction TLT $-1.340 -0.01% 3,162,857 21.67% 6,425,593 44.03% -3,262,736 -24,349 GDXJ $-1.290 -0.03% 4,139,810 14.90% 11,111,097 40.00% -6,971,287 -54,041 CBIS $-0.012 -0.10% 50,545,354 44.42% 63,221,128 55.56% -12,675,774 -10,222,398 MJNA $-0.015 -0.10% 15,732,646 31.01% 32,900,785 64.85% -17,168,139 -11,600,094 JNUG $-1.170 -0.10% 19,775,947 36.91% 22,187,237 41.41% -2,411,290 -20,609 ABEV $-0.030 -0.01% 3,980,262 17.61% 10,897,079 48.21% -6,916,817 -2,305,606Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows TLT down $-1.34000 with a Friction Factor of -24,349 and a Net Volume of -3,262,736. That means that it takes 24,349 more shares of selling than buying to drop TLT by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).
iSh 20+Y Trs Bd Shs (NASDAQ:TLT) - The investment seeks to track the investment results of the ICE U.S. Treasury 20+ Year Bond Index (the "underlying index"). The fund generally invests at least 90% of its assets in the bonds of the underlying index and at least 95% of its assets in U.S. government bonds. The underlying index measures the performance of public obligations of the U.S. Treasury that have a remaining maturity greater than twenty years..
MARKET VECTORS ETF TRJR GOLD MINES (NYSE:GDXJ) - Market Vectors Etf Trust Marke.
CANNABIS SCIENCE Inc. (OTC:CBIS) - Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phyto cannabinoid-based pharmaceutical products primarily in the United States. The company is involved in developing medicines for autism, blood pressure, cancer and cancer side effects, as well as for other illnesses comprising for general health maintenance. It also develops CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has a license agreement with Apothecary Genetics Investments LLC to produce various brand formulations for California medical cannabis market; and collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug. The company also has a collaborative research agreement with Dana Farber/Harvard Cancer Center to explore and develop cannabinoid medicines to fight cancer. Cannabis Science, Inc. is based in Colorado Springs, Colorado. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc..
MEDICAL MARIJUANA I (OTC:MJNA) - Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California..
Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG) - .
Ambev S.A. (NYSE:ABEV) - .
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net